# ZIMHI
> **NDA212854** · New Drug Application · Sponsor: ZMI PHARMA · Approved 2021-10-15
## Drug
- **FDA Application Number:** NDA212854
- **Application type:** New Drug Application
- **Brand name:** ZIMHI
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ZMI PHARMA
- **Manufacturer:** ZMI Pharma Inc.
- **First approval:** 2021-10-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212854)
---
*MORVS · CC0 1.0*